Home›Companies›Healthcare›Starling Medical

Starling Medical, Inc.

At-home urine monitoring for patients and their healthcare providers.

Updated Nov 10, 2026·Latest SEC filing Mar 19, 2026·Suggest an edit

About Starling Medical

Starling Medical is a private company based in Houston, Texas. It has reported $9,715,596 raised in two offerings on Form D since September 2024. Its chief executive is Hannah McKenney.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 27, 2026Mar 19, 2026$824,990of $1.7M target5$164KEquityRule 506(b)Form D ↗
Sep 6, 2024Sep 18, 2024amended Dec 9, 2024$8,890,606fully sold40$222KEquityRule 506(b)Form D/A ↗1 earlier filing
Total, two offerings$9,715,596

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Starling Medical's Form D filed Mar 19, 2026.

HM
Hannah McKenney
Chief Executive Officer and director
Shana Barghouti
Shana Barghouti
Director
Also a board member at Gradient Health.

Sources

  1. SECStarling Medical, Inc. Form D, filed Sep 18, 2024
  2. SECStarling Medical, Inc. filing history
  3. CompanyStarling Medical contact